Fig 3. Proportion of specimens with infectious virus over the infectious period.

Correlation between the maximum viral RNA level (N copies/ml) for a given participant and the infectious viral titer of that same nasal specimen. Pearson’s correlation was used to assess the strength of the correlation. B) The proportion of nasal samples with infectious virus in unvaccinated and vaccinated participants by day post symptom onset. The number of specimens assessed at each time point is indicated in the lower box. The last column is a sum of all samples assessed from day 15 onwards. Logistic regression analysis spanning days 1–5 and 6–12 was done to assess statistically significant differences between groups.